Goblet cell transplantation is promising treatment for severe ocular surface disorders

Article

Goblet cell transplantation using autologous turbinate nasal mucosa is a promising treatment for severe ocular surface diseases.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
Related Content
A magnet sits in a pile of iron filings. Image credit: ©New Africa – stock.adobe.com

Magnetic cell therapy for corneal endothelial dysfunction

By Lynda Charters; Reviewed by Sumit Garg, MD, ABO
September 6th 2024
Article

Phase 1 multicentre study data demonstrate early signs of efficacy

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
July 22nd 2024
Podcast
Barcelona at night, specifically the area around Fira de Barcelona convention center. Image credit: ©JackF – stock.adobe.com

Filomena Ribeiro, MD, PhD, FEBO, discusses escape rooms, inclusivity initiatives and everything else ESCRS

Hattie Hayes
September 4th 2024
Article

Dr Ribeiro, President of the European Society of Cataract and Refractive Surgeons, previewed the 2024 congress

A digital interface of a rocket ship launching, to represent a product launch. Image credit: ©VRVIRUS – stock.adobe.com

BVI announces launch of SERENITY and SERENITY Toric IOLs at ESCRS

Martin David Harp
September 3rd 2024
Article

The non-diffractive, aspheric IOLs are the second generation of BVI’s ISOPURE family

A child stands on a scale in the doctor's office and looks at the scale with the doctor. Image credit: ©rocketclips – stock.adobe.com

Corneal nerve regeneration following semaglutide therapy

By Lynda Charters; Reviewed by Rayaz Malik, MBCHB, PhD, and Hoda Gad, BSc, MSc, PhD
September 2nd 2024
Article

A case report demonstrates independent effect of GLP-1 receptor agonist

A robot with a lab coat on consults a clipboard. Image credit: ©catalin – stock.adobe.com

The digital OR: Retina care of tomorrow

Mark Barakat, MD
August 30th 2024
Article

The future of the tech-forward surgical suite

© 2024 MJH Life Sciences

All rights reserved.